Mingen Lin
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Epigenetics and DNA Methylation 3
- DNA Repair Mechanisms 2
- Oncology 5
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Lei Lv (10 shared papers)Ming‐Liang Lai (1 shared paper)Yanping Xu (8 shared papers)Chuanmin Cheng (1 shared paper)Jin‐ding Huang (1 shared paper)Ruonan Zhang (6 shared papers)Wenjing Dong (2 shared papers)Tongguan Tian (5 shared papers)
- Journals
- Cell Death and Disease (2 papers)Cell Discovery (1 paper)Molecular Therapy — Oncolytics (1 paper)Frontiers in Oncology (1 paper)Cancer Research (1 paper)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Mingen Lin
18 papers receiving 502 citations
Mingen Lin's Hit Papers
Peers
Comparison fields: 5 of 78
- Pharmacology 116
- Transplantation 16
- Oncology 153
- Immunology 79
- Cancer Research 54
Countries citing papers authored by Mingen Lin
This map shows the geographic impact of Mingen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingen Lin more than expected).
Fields of papers citing papers by Mingen Lin
This network shows the impact of papers produced by Mingen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingen Lin. The network helps show where Mingen Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingen Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1 Hit paper breakdown → | 2022 | 167 |
| 2 | Novel mutations of CYP3A4 in Chinese. | 2001 | 166 |
| 3 | 2023 | 40 | |
| 4 | 2022 | 37 | |
| 5 | 2023 | 16 | |
| 6 | 2020 | 13 | |
| 7 | 2023 | 12 | |
| 8 | 2023 | 11 | |
| 9 | 2024 | 8 | |
| 10 | 2024 | 8 | |
| 11 | 2020 | 6 | |
| 12 | 2025 | 6 | |
| 13 | 1984 | 6 | |
| 14 | 2022 | 4 | |
| 15 | 1993 | 4 | |
| 16 | 2015 | 4 | |
| 17 | 2025 | 1 | |
| 18 | 2005 | 1 |
About Mingen Lin
Mingen Lin is a scholar working on Molecular Biology, Oncology, Cell Biology, Immunology and Epidemiology, having authored 18 papers that have together received 510 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Immune Cell Function and Interaction (3 papers), Epigenetics and DNA Methylation (3 papers), DNA Repair Mechanisms (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers), Immunotherapy and Immune Responses (2 papers) and Autophagy in Disease and Therapy (2 papers). The work is most often cited by research in Pharmacology (116 citations), Transplantation (16 citations), Oncology (153 citations), Immunology (79 citations) and Cancer Research (54 citations). Mingen Lin has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Lei Lv, Ming‐Liang Lai, Yanping Xu, Chuanmin Cheng, Jin‐ding Huang, Ruonan Zhang, Wenjing Dong, Tongguan Tian, Yajing Yang and Jing He. Their work appears in journals such as Cell Death and Disease, Cell Discovery, Molecular Therapy — Oncolytics, Frontiers in Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.